Bio-Rad Laboratories Class A
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.About BIO
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics.
BIO Key Statistics
Stock Snapshot
As of today, Bio-Rad Laboratories Class A(BIO) shares are valued at $381.57. The company's market cap stands at 10.32B, with a P/E ratio of 10.05.
On 2026-11-08, Bio-Rad Laboratories Class A(BIO) stock traded between a low of $365.16 and a high of $384.62. Shares are currently priced at $381.57, which is +4.5% above the low and -0.8% below the high.
Bio-Rad Laboratories Class A(BIO) shares are trading with a volume of 268.89K, against a daily average of 252.81K.
In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $396.23 and a 52-week low of $236.73.
In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $396.23 and a 52-week low of $236.73.
BIO News
Bio-Rad Laboratories reported Q3 2026 sales of US$656.4 million and net income of US$458.6 million, with earnings per share from continuing operations above US$...
Bio-Rad Laboratories, Inc. ( ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to US$369 in the week after its latest third-...
Bio-Rad Laboratories (BIO) is back on investors’ radar as CFO Roop K. Lakkaraju heads into a fireside chat at the UBS Global Healthcare Conference, alongside fr...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.